Bayesian Adverse Event Prediction From Physiological Diagnostic States
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical devices fail to provide early warnings for heart failure and other cardiovascular conditions until they become physically manifest, leading to undesirable hospitalizations.
Innovation Solution
A system using prediction and probability modeling based on physiological parameters, including subcutaneous tissue impedance and heart rate variability, to determine the likelihood of adverse health events, employing Bayesian frameworks and integrated diagnostics to generate alerts.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional medical monitoring methods are used, then device complexity is reduced, but detection precision and early warning capability deteriorate
Solution Approach 1:
The system segments the monitoring function into multiple independent physiological parameter sensors (heart rate, respiratory rate, oxygen saturation, temperature, activity level) that can be individually implemented and combined. This allows gradual increase in detection precision without requiring a complete complex system redesign.
Solution Approach 2:
The medical device is designed with multi-functionality, integrating multiple physiological parameter monitoring capabilities into a single device. This universal approach improves early detection precision across different conditions while managing complexity through consolidation rather than proliferation of separate devices.
2Measurement precision
If multiple physiological parameters are monitored, then detection precision improves, but loss of information increases due to data complexity
Solution Approach 1:
The system implements feedback mechanisms where collected physiological data is continuously analyzed and compared against baseline values and clinical thresholds. This feedback loop transforms raw multi-parameter data into actionable clinical insights, preventing information loss by systematically processing and interpreting the data rather than merely collecting it.
Solution Approach 2:
The system performs preliminary analysis and pattern recognition on physiological data before clinical decisions are made. By pre-processing the multi-parameter data to identify trends, anomalies, and predictive patterns, the system reduces the cognitive load on clinicians and prevents information loss through systematic preliminary evaluation.
3Productivity
If early prediction systems are implemented, then productivity in terms of preventive care improves, but device complexity increases
Solution Approach 1:
The system performs preliminary risk assessment and prediction modeling in advance of adverse events. By continuously analyzing physiological patterns and predicting potential deterioration before it occurs, the system improves preventive care productivity while managing complexity through proactive rather than reactive monitoring.
Solution Approach 2:
The prediction system operates with a degree of autonomy, automatically analyzing data patterns and generating risk assessments without requiring constant clinical intervention. This self-service capability improves preventive care efficiency by continuously monitoring and alerting to potential issues while reducing the operational complexity burden on healthcare providers.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables early detection and prediction of heart failure and other cardiovascular conditions, allowing proactive medical interventions and reducing hospitalizations.
Implementation Method 1
an implantable medical device (IMD) including a plurality of electrodes and configured for subcutaneous implantation in a patient, wherein the IMD is configured to determine one or more subcutaneous tissue impedance measurements via the electrodes
Data Source
AI summary
Techniques for determining a likeliness that a patient may incur an adverse health event are described. An example technique may include utilizing a probability model that uses as evidence nodes various diagnostic states of physiological parameters, which may include one or more subcutaneous impedance parameters. The probability model may include a Bayesian Network that determines a posterior probability of the adverse health event occurring within a predetermined period of time.


